ReviewFrontiers in immunology2022

Targeting myeloid villains in the treatment with immune checkpoint inhibitors in gastrointestinal cancer.

Chie Kudo-Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.